Previous 10 | Next 10 |
Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +100% . More news on: Sonnet BioTherapeutics Holdings, Inc., MEI Pharma, Inc., NantKwest, Inc., Stocks on the move, Read more ...
Immunotherapy companies led by Dr. Patrick Soon-Shiong are developing potential coronavirus therapeutics and vaccines to address the evolving stages of disease from moderate infection to severe acute respiratory distress syndrome (SARS) Vaccine Vector to Protect Against SARS-CoV-2 I...
The first patient has been dosed in a Phase 2 clinical trial evaluating NantKwest's (NASDAQ: NK ) off-the-shelf natural killer (NK) cells, combined with Immunity Bio's IL-15 superagonist N-803 and Pfizer's (NYSE: PFE ) Bavencio (avelumab), in patients with Merkel cell carcinoma (MCC) ...
Clinical trial for patients failing checkpoint therapy uses combination of first-in-class, cryopreserved, CD16 NK cells, ImmunityBio’s IL-15 superagonist and checkpoint inhibitor Avelumab NantKwest, Inc. (Nasdaq: NK), a next-generation, clinical-stage immunotherapy company focus...
Gainers: Bellerophon Therapeutics (NASDAQ: BLPH ) +144% . More news on: Bellerophon Therapeutics, Inc., Brickell Biotech, Inc., Wanda Sports Group Company Limited, Stocks on the move, , Read more ...
Gainers: Neon Therapeutics (NASDAQ: NTGN ) +44% . More news on: Neon Therapeutics, Inc., NantKwest, Inc., Signet Jewelers Limited, Stocks on the move, , Read more ...
After the company unveiled an exciting progress report at the J.P. Morgan Healthcare Conference, shares of NantKwest (NASDAQ: NK) , a clinical-stage biotech that uses natural killer (NK) cells to fight cancer, surged 70% as of 11:19 a.m. EST on Thursday. NantKwest issued a press relea...
Complete Responses Noted in Multiple Tumor Types (including Pancreatic Cancer, Triple Negative Breast Cancer, Head and Neck Cancer, Merkel Cell Cancer, Bladder Cancer, and Non-Hodgkin’s Lymphoma) when Natural Killer cells and T cells are activated simultaneously FDA Registration...
Gainers: RTI Surgical RTIX +66% . More news on: IRIDEX Corporation, Inpixon, Gritstone Oncology, Inc., Stocks on the move, , Read more ...
World’s first combination of tumor-targeted, off-the-shelf PD-L1-targeted Natural Killer cells with IL-15 fusion protein (N-803) to induce immune system activation of both the NK and T-cells demonstrated complete response in second-line metastatic pancreatic cancer, confirmed by PET...
News, Short Squeeze, Breakout and More Instantly...
NantKwest Company Name:
NK Stock Symbol:
NASDAQ Market:
Imerys Enters Long-Term Partnership with TotalEnergies for Renewable Power at its Santa Barbara County Facility PR Newswire A TotalEnergies solar and battery storage solution to bring 130-year-old Lompoc industrial site into new era of sustainability and smart energy manag...
Creates Leading Immunotherapy and Cell Therapy Company ImmunityBio , Inc. and NantKwest , Inc. ( NASDAQ: NK ), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing conditi...
NantKwest, Inc . ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the pending merger of NantKwest and ImmunityBio, Inc. presented at the special ...